Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shinri International Group is a comprehensive healthcare service provider specializing in reproductive medicine, genetic testing, and high-end health management. The company is a prominent player in the cross-border medical market, particularly for third-generation IVF (In Vitro Fertilization) services, offering genetic screening (PGD/PGS) to international patients. Beyond reproductive health, Shinri provides services in anti-aging, cell therapy, and chronic disease management through its network of clinics and partnerships in Hong Kong, Thailand, and the United States. The group focuses on delivering personalized medical solutions and high-quality patient care for the Asian market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shinri International Group.